$SYM

KRASNOW TODD sold $88K of SYM (indirect holdings)

KRASNOW TODD sold 2,000 indirectly-held shares of Symbotic Inc. (SYM) at an average of $43.92 ($43.87–$44.41) across 2 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KRASNOW TODD
Published Jul 8, 2026, 10:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
high confidence
Mentioned
$SYM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

Because the transaction is pre-planned and relatively small in value, it is more likely to be informational for insider activity tracking than a driver of earnings or guidance expectations.

02

Market read

Traders may log the sale for insider-flow monitoring, but there is no new fundamental catalyst in the text.

03

What to watch

The filing specifies indirect holdings and post-transaction ownership of 0 shares, but it does not clarify the size of remaining indirect exposure outside this reported position.

Relevance 2/10Novelty 2/10Timing: Filed 2026-07-08 after the 2026-07-06 sale under a 10b5-1 plan.

Background

The article is a primary-source SEC Form 4 insider transaction for Symbotic director KRASNOW TODD, reporting an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$SYMNeutralHigh confidence
Context

Symbotic disclosed a director’s indirect open-market sale of 2,000 shares on 2026-07-06 under a 10b5-1 plan, totaling about $87.8K.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment noise.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly under a pre-arranged 10b5-1 plan, with a small dollar value relative to typical market capitalization and no accompanying company-specific news.

Market effects

Minimal. The disclosure is company-specific and does not indicate broader sector developments.

Minimal. No cross-regional or macro linkage is provided.

Minimal. No international transaction or regulatory action is mentioned.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can sometimes coincide with private views on valuation or liquidity needs, so traders may still watch for follow-on sales.

Key entities

  • Symbotic Inc.

    Company whose director’s Form 4 reports an indirect open-market sale of 2,000 shares under a 10b5-1 plan.

  • KRASNOW TODD

    Director reporting an indirect sale totaling about $87,842.94, with holdings after transaction of 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMHigh

A sorter steers goods in any direction, replacing traditional conveyor systems

Symbotic Inc. (SYM) acquired cellumation GmbH, a German automation company, for its celluveyor technology. The celluveyor is a software-driven sortation platform that replaces traditional conveyors, offering greater density, throughput, and efficiency. Symbotic aims to integrate the technology into its systems and expand its European presence. cellumation will continue operating independently, serving its global customer base.

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.